What Is The Difference Between Von Willebrand Disease And Haemophilia?
Understanding two often-confused bleeding disorders.
- Different proteins involved
- Different inheritance patterns
- Different bleeding presentations
When people hear the term “bleeding disorder”, haemophilia is often the first condition that comes to mind. It is one of the most recognised inherited bleeding disorders in the world, largely due to decades of awareness campaigns, specialist treatment centres, and media coverage.
However, there is another bleeding disorder that is actually more common than haemophilia: Von Willebrand Disease (VWD).
Despite affecting significantly more people, Von Willebrand Disease remains relatively unknown outside specialist healthcare circles. Many people have never heard of it until they or a family member receive a diagnosis.
Because both conditions affect the body’s ability to form blood clots, they are often confused. Yet they are distinct disorders with different causes, inheritance patterns, symptoms, and treatment approaches.
In this article, we explore the key differences between Von Willebrand Disease and haemophilia, helping patients, families, and healthcare professionals better understand these important conditions.
2
different disorders
Although they are often grouped together as inherited bleeding disorders, Von Willebrand Disease and haemophilia differ in the protein affected, who they commonly affect, how bleeding presents, and how they are treated.
What Do Von Willebrand Disease And Haemophilia Have In Common?
Before looking at the differences, it is worth understanding what these conditions share.
Both Von Willebrand Disease and haemophilia are:
- Inherited bleeding disorders
- Caused by problems with blood clotting proteins
- Associated with prolonged bleeding
- Diagnosed through specialist blood testing
- Managed by haemophilia and bleeding disorder specialists
- Lifelong conditions
In both disorders, the body’s ability to stop bleeding is impaired. This means people may bleed for longer after injuries, surgery, dental procedures, or other forms of trauma.
However, the reason this happens is very different.
What Is Haemophilia?
Haemophilia is a genetic bleeding disorder caused by a deficiency of specific clotting factors that help blood form stable clots.
The two most common forms are:
Haemophilia A
Caused by low levels of Factor VIII (Factor 8).
Haemophilia B
Caused by low levels of Factor IX (Factor 9).
The severity of haemophilia is largely determined by how much clotting factor is present in the blood. People with very low levels are more likely to experience spontaneous bleeding and serious complications.
What Is Von Willebrand Disease?
Von Willebrand Disease is caused by a deficiency or dysfunction of a protein called Von Willebrand Factor (VWF).
Von Willebrand Factor has two important jobs:
1. Helping Platelets Stick Together
When a blood vessel is damaged, VWF helps platelets gather at the injury site to form an initial plug.
2. Protecting Factor VIII
VWF acts as a carrier protein for Factor VIII, helping protect it from being broken down too quickly in the bloodstream.
Without enough functioning VWF, blood clotting becomes less effective.
There are three main types of Von Willebrand Disease:
- Type 1 (partial deficiency)
- Type 2 (functional defect)
- Type 3 (near complete absence of VWF)
Type 1 accounts for approximately 70–80% of diagnosed cases.
The Key Difference: Which Protein Is Missing?
The simplest way to understand the distinction is:
| Condition | Protein Affected |
|---|---|
| Haemophilia A | Factor VIII |
| Haemophilia B | Factor IX |
| Von Willebrand Disease | Von Willebrand Factor |
Although VWD can also lead to lower Factor VIII levels, the primary problem is the Von Willebrand Factor itself.
Think of VWF as both a “sticky glue” that helps platelets form an initial clot and a protective transport system for Factor VIII.
Without it, the clotting process becomes less effective.
Which Condition Is More Common?
Many people are surprised to learn that Von Willebrand Disease is considerably more common than haemophilia.
Von Willebrand Disease
Around 1% of the population may have reduced levels of Von Willebrand Factor, although many people experience only mild symptoms.
Haemophilia
Haemophilia A affects approximately 1 in 5,000 male births, while Haemophilia B affects around 1 in 25,000 male births.
Despite being more common, VWD is often underdiagnosed because symptoms can be mild and easily mistaken for normal variations in bleeding.
Do They Affect Men And Women Equally?
This is one of the biggest differences between the two conditions.
Haemophilia
Haemophilia is usually inherited through the X chromosome. Because males have only one X chromosome, they are far more likely to develop the condition. Females can have haemophilia, but it is much less common.
Von Willebrand Disease
VWD is usually inherited through non-sex chromosomes (autosomal inheritance), meaning it affects males and females equally.
In practice, however, women are often diagnosed more frequently because symptoms such as heavy menstrual bleeding and childbirth-related bleeding bring the condition to medical attention.
Are The Symptoms Different?
Although symptoms overlap, there are some important differences.
Common Symptoms Of Von Willebrand Disease
- Frequent nosebleeds
- Easy bruising
- Bleeding gums
- Heavy menstrual bleeding
- Prolonged bleeding after cuts
- Excessive bleeding following surgery or dental treatment
Many symptoms involve bleeding from mucous membranes such as the nose, mouth, and reproductive system.
Common Symptoms Of Haemophilia
- Deep muscle bleeds
- Joint bleeding
- Painful swelling
- Internal bleeding episodes
- Spontaneous bleeding without injury
Repeated bleeding into joints can cause long-term joint damage if not properly managed.
Which Condition Is More Severe?
There is no simple answer.
Severity varies considerably between individuals.
Mild Von Willebrand Disease
Many people with Type 1 VWD may live for years without diagnosis and only experience problems during surgery, dental work, or childbirth.
Severe Von Willebrand Disease
People with Type 3 VWD can experience severe bleeding episodes that resemble severe haemophilia.
Haemophilia
Severity depends on the level of clotting factor present. People with severe haemophilia may experience spontaneous bleeding into joints and muscles without obvious injury.
As a result, severe haemophilia is generally associated with a higher risk of spontaneous internal bleeding than most forms of VWD.
How Are They Diagnosed?
Diagnosis for both conditions involves specialist blood testing.
Haemophilia Testing
Tests typically measure:
- Factor VIII levels
- Factor IX levels
- Clotting function
Von Willebrand Disease Testing
Testing is often more complex and may include:
- VWF antigen levels
- VWF activity tests
- Factor VIII levels
- Additional specialised clotting studies
Diagnosing VWD can be particularly challenging because Von Willebrand Factor levels naturally fluctuate due to stress, illness, exercise, hormonal changes, and pregnancy. Multiple tests may be required before a diagnosis can be confirmed.
Are Treatments Similar?
Both conditions now have highly effective treatments, but the therapies differ.
Treatments For Haemophilia
May include:
- Factor VIII replacement
- Factor IX replacement
- Extended half-life therapies
- Preventive (prophylactic) treatment
- Newer non-factor therapies
Treatments For Von Willebrand Disease
May include:
- Desmopressin (DDAVP)
- Von Willebrand Factor concentrates
- Factor VIII concentrates
- Antifibrinolytic medications
- Hormonal treatments for heavy menstrual bleeding
Treatment is tailored to the individual’s condition, symptoms, and bleeding risk.
Why Is Von Willebrand Disease Often Compared To Haemophilia?
Historically, haemophilia has received significantly more public awareness and research attention.
This has led many people to use haemophilia as a reference point when trying to understand other bleeding disorders.
However, comparing VWD to haemophilia can sometimes be misleading.
While both affect blood clotting, Von Willebrand Disease has unique symptoms, diagnostic challenges, and treatment requirements.
Recognising these differences is important for improving awareness, reducing delays in diagnosis, and ensuring patients receive appropriate care.
